Effects of alogliptin on the ratio of glycated albumin to HbA1c in patients with type 2 diabetes mellitus

The ratio of glycated albumin (GA) to HbA1c (the GA/HbA1c ratio) has been used as a glycemic control indicator that reflects postprandial plasma glucose levels or glycemic variability. In this study, we investigated the effects of alogliptin, a DPP-4 inhibitor, on the GA/HbA1c ratio in patients with...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Diabetol Int
Prif Awduron: Masumoto, Norio, Otsuki, Hiroaki, Iwakawa, Seigo, Inada, Shinya, Goya, Kayoko, Sho, Hiroyuki, Suzuki, Satoko, Kurebayashi, Shogo, Hashimoto, Kunihiko, Koga, Masafumi
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Springer Japan 2016
Pynciau:
Original Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC6224958/
https://ncbi.nlm.nih.gov/pubmed/30603324
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13340-016-0298-3
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg